FTC May Investigate Transgender Medicine Industry

The Federal Trade Commission (FTC) has a clear basis to begin an investigation into the transgender medicine sector. This follows a recent workshop that featured numerous alarming accounts from stakeholders, according to Mark Meador from the FTC.

The workshop, held on Wednesday, was titled “The Dangers of Gender-Affirming Care for Minors.” It aimed to gather information from parents and patients to assess whether the transgender industry has misled families.

“They presented some really concerning information that certainly supports our need to investigate further,” Meador commented in an interview after the session.

He mentioned that while there are various details to confirm—like ensuring everything is thoroughly checked—the insights gained from the workshop provide strong justification to pursue an inquiry into possible violations.

The FTC is authorized to investigate practices deemed “unfair or deceptive” that could harm consumers.

In its investigation, the FTC has the authority to issue subpoenas, requiring individuals and organizations to submit documents and provide testimony. Additionally, the FTC considers input from third parties to decide if laws have been breached.

Next week, the FTC plans to make a public request for more information regarding transgender medical interventions, as announced by Chairman Andrew Ferguson.

This step is intended to clarify who should be consulted, which questions to ask, and what potential harms to monitor, according to Meador.

A significant aspect of the potential misleading claims relates to comments from medical professionals suggesting to parents that the only choices are “a dead son or a living daughter,” or the other way around. Meador described some of this rhetoric as “emotional blackmail.”

“We need to determine if such a statement is deceptive or true, and that will definitely be part of our investigation,” he added.

Should the FTC find a violation of the law, it can present the case in court to seek injunctions against continued unlawful practices.

“If we go to court and can prove our case, we might get a judge to declare that certain actions break FTC regulations,” Meador explained. “Ideally, we’d receive an order preventing companies or individuals from such behavior.”

He emphasized that the FTC aims to hold accountable anyone involved in misleading activities.

“We don’t want to just address one part of the issue while leaving others unchallenged,” he stated. “It’s essential to seek remedies that apply broadly to all parties engaged in deceptive practices.”